Drugs & medicalClass II

Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by:…

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Read the official notice →
Date
2025-03-26
Country
United States
Brand
Slate Run Pharmaceuticals
Product
Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by:…
Classification
Class II
Units
Product was distributed to 8 distributors who may have further distribute the…
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Slate Run Pharmaceuticals recalls

  1. 2026-03-04
  2. US
    Drugs & medicalClass III

    Slate Run Pharmaceuticals recalls Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx…

    Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

    FDA · DrugSlate Run PharmaceuticalsNationwide within the USA.Official notice →
All 2 Slate Run Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2025-03-26
  2. US
    Drugs & medicalClass II

    FDC Limited recalls Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ.…

    Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

    FDA · DrugFDC LimitedNationwide in the U.SOfficial notice →
  3. US
    Drugs & medicalClass I

    One Source Nutrition, Inc, recalls Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme…

    Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.

    FDA · DrugOne Source Nutrition, Inc,Nationwide in the U.S.AOfficial notice →
  4. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…

    Failed Dissolution Specifications - low dissolution results

    FDA · DrugMYLAN PHARMACEUTICALS INCUS Nationwide.Official notice →
  5. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USA.Official notice →
  6. 2025-03-20
  7. US
    Drugs & medical

    Woolite Delicates Detergent Recalled by Reckitt Due to Risk of Exposure to Bacteria; Sold Exclusively on Amazon.com

    The recalled products can contain Pseudomonas species bacteria, including Pseudomonas oleovorans, an environmental organism found widely in soil and water. People with weakened immune systems or external medical…

    CPSCReckitt Benckiser LLC, of Parsippany, New JerseyAbout 16,200Official notice →
  8. 2025-03-19
  9. US
See all drugs & medical recalls →